Related Experiment Video
Updated: Oct 5, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System
Zhichao Min1, Yuanyuan Mi2, Zhiwei Lv3
1Department of Urology, The First People's Hospital of Hangzhou Lin'an District, Hangzhou 310000, China.
Background:
Genetic polymorphisms in mammalian target of rapamycin (mTOR) signaling axis can influence the susceptibility of cancer. The relationship between mTOR gene variants rs2295080 T/G and rs1883965 G/A and the risk of cancer remains inconsistent. The present study is aimed at comprehensively investigating the association between mTOR polymorphisms and susceptibility to cancer.
Methods:
We conducted a comprehensive assessment using odds ratios (ORs), corresponding 95% confidence intervals (CIs), and in silico tools to evaluate the effect of mTOR variations. Immunohistochemical staining (IHS) and GSEA analysis were used to investigate the expression of mTOR in urinary system cancer.
Results:
The pooled analysis involved 22 case-control studies including 14,747 cancer patients and 16,399 controls. The rs2295080 T/G polymorphism was associated with the risk of cancer (G-allele versus T-allele, OR = 0.89, 95%CI = 0.80-0.98, P = 0.023; GT versus TT, OR = 0.88, 95%CI = 0.81-0.96, P = 0.004; GG+GT versus TT, OR = 0.87, 95%CI = 0.78-0.96, P = 0.008), especially for cancers of the urinary system, breast, and blood. Variation rs1883965 G/A was associated with cancer susceptibility, especially for digestive cancer. IHS analysis showed that mTOR was upregulated in prostate and bladder cancer. GSEA revealed that the insulin signaling pathway, lysine degradation pathway, and mTOR signaling pathway were enriched in the high mTOR expression group.
Conclusions:
The mTOR rs2295080 T/G polymorphism may be associated with susceptibility of urinary cancer. The expression of mTOR is positively correlated with tumor malignancy in prostate cancer.
Insights
Genetic variations in the mammalian target of rapamycin (mTOR) pathway, specifically the rs2295080 T/G polymorphism, are linked to increased cancer risk, particularly for urinary system cancers. This finding aids in understanding cancer susceptibility and progression.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Genetic polymorphisms in the mammalian target of rapamycin (mTOR) signaling pathway can affect cancer susceptibility.
- Previous studies on mTOR gene variants rs2295080 T/G and rs1883965 G/A and cancer risk have yielded inconsistent results.
Purpose of the Study:
- To comprehensively investigate the association between mTOR gene polymorphisms and cancer susceptibility.
- To evaluate the impact of specific mTOR variants (rs2295080 T/G and rs1883965 G/A) on cancer risk.
Main Methods:
- A pooled analysis of 22 case-control studies (14,747 cancer patients, 16,399 controls).
- Statistical assessment using odds ratios (ORs) and 95% confidence intervals (CIs).
- In silico tools, immunohistochemical staining (IHS), and Gene Set Enrichment Analysis (GSEA) to evaluate mTOR expression and pathway enrichment.
Main Results:
- The rs2295080 T/G polymorphism was significantly associated with overall cancer risk (e.g., G-allele vs. T-allele: OR=0.89, P=0.023), particularly for urinary system, breast, and blood cancers.
- The rs1883965 G/A variation showed an association with digestive cancer susceptibility.
- IHS revealed mTOR upregulation in prostate and bladder cancers, with GSEA indicating enrichment of insulin and mTOR signaling pathways in high mTOR expression groups.
Conclusions:
- The mTOR rs2295080 T/G polymorphism may contribute to urinary cancer susceptibility.
- mTOR expression levels are positively correlated with tumor malignancy in prostate cancer, suggesting its role in disease progression.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Single Nucleotide Polymorphisms-SNPs
The Ras Gene
Ras is a...
Cancer Prevention
Some...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

